Ñî¹óåú´«Ã½Ò•îl

When I walked into my last doctor’s appointment, I had to do a double take. The physician who entered the room looked like a teenager. I don’t mean that in a dismissive way — she was just unmistakably young. Clear skin, easy smile, an iPad, no clipboard. She introduced herself, apologized for running a few minutes behind, and sat down. (Frantz M. Berthaud, 7/7)

The future of biotechnology will increasingly be shaped by artificial intelligence, genomic medicine, cell and gene therapies, advanced diagnostics and new manufacturing technologies, all areas California pioneered and is uniquely positioned to lead. But in a global market, leadership follows science and investment, not first roots. (Tim Scott, 7/6)

In 2014, we came far closer to losing control of Ebola than most people realize. We witnessed impossible choices daily, such as watching treatment centers turning away infected patients because there were no beds left. The epidemic eventually receded, but not because anyone had mastered Ebola. It ended because of extraordinary international cooperation, local adaptations, and no small measure of luck. (Ivan Buendia Gayton and Eric D. Perakslis, 7/7)

The publication of the study in another journal doesn’t erase the troubling questions raised by its suppression. (Leana S. Wen, 7/7)